Beta-Lactam Compounds for Long-Acting Glucose Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for glucose metabolism disorders, such as diabetes, often require frequent injections and do not consistently maintain glycemic targets, leading to challenges in patient compliance and effective glucose level control.
Innovation Solution
Administration of a beta-lactam compound or its pharmaceutically acceptable salt, which provides a long-acting effect in preventing or treating glucose metabolism disorders, potentially lasting for several weeks after a single administration, by regulating blood glucose levels and improving insulin sensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current insulin treatments are used, then glucose level control is achieved, but frequent injections are required leading to poor patient compliance
Solution Approach 1:
The patent applies dynamics by transitioning from static, short-acting insulin formulations to dynamic, long-acting formulations with extended half-lives. The beta-lactam compounds and their metabolites create a time-dependent therapeutic effect that adapts to the patient's needs over extended periods, reducing injection frequency while maintaining glucose control reliability.
Solution Approach 2:
The patent implements preliminary action through the use of prodrugs and compounds that are converted to active metabolites in the body. The beta-lactam compounds undergo metabolic transformation to produce active species that provide prolonged therapeutic effects, effectively preparing the system in advance for sustained glucose management without requiring frequent re-administration.
2Ease of operation
If long-acting insulin treatments are used, then injection frequency is reduced, but the duration of action is still insufficient
Solution Approach 1:
The patent achieves continuity of useful action by designing beta-lactam compounds that maintain therapeutic levels in the body for extended periods. The compounds and their metabolites create a continuous therapeutic presence, ensuring sustained glucose metabolism regulation without interruption, thereby reducing injection frequency while extending duration of action beyond current long-acting insulins.
Solution Approach 2:
The patent applies parameter changes by modifying the chemical structure and pharmacokinetic properties of the compounds to achieve extended half-lives. The beta-lactam compounds exhibit altered metabolic parameters compared to traditional insulins, with extended circulation times and prolonged active metabolite presence, thereby achieving both reduced injection frequency and extended duration of therapeutic effect.
3Reliability
If frequent injections are required, then glucose targets can be maintained, but patient compliance deteriorates
Solution Approach 1:
The patent implements self-service through the body's natural metabolic processes that convert the administered beta-lactam compounds into active therapeutic metabolites. The compounds leverage the body's own enzymatic systems to generate and sustain therapeutic effects, reducing the burden on patients while maintaining reliable glycemic control through endogenous activation and prolonged action.
Data Source
AI summary
Provided is a long-acting method for preventing or treating glucose metabolism disorders that includes administering a beta-lactam compound or a pharmaceutically acceptable salt thereof to a subject in need thereof. The method for preventing or treating glucose metabolism disorders has a long-acting effect that lasts more than two days even after medication has been stopped.